Editors:
- Provides a new strategy to advance the clinical care of patients.
- Provides a comprehensive overview of HCC diagnosis, treatment, and prevention.
- Written by experts in the field.
Part of the book series: Molecular and Translational Medicine (MOLEMED)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (17 chapters)
-
Front Matter
-
Clinical Demographics and Management
-
Front Matter
-
-
Diagnosis and Prognostication
-
Front Matter
-
-
Treatment
-
Front Matter
-
-
Molecular Pathogenesis and Therapeutic Discovery
-
Front Matter
-
About this book
This book provides a comprehensive overview of the current limitations and unmet needs in Hepatocellular Carcinoma (HCC) diagnosis, treatment, and prevention. It also provides newly emerging concepts, approaches, and technologies to address challenges. Topics covered include changing landscape of HCC etiologies in association with health disparities, framework of clinical management algorithm, new and experimental modalities of HCC diagnosis and prognostication, multidisciplinary treatment options including rapidly evolving molecular targeted therapies and immune therapies, multi-omics molecular characterization, and clinically relevant experimental models. The book is intended to assist collaboration between the diverse disciplines and facilitate forward and reverse translation between basic and clinical research by providing a comprehensive overview of relevant areas, covering epidemiological trend and population-level patient management strategies, new diagnostic and prognostic tools, recent advances in the standard care and novel therapeutic approaches, and new concepts in pathogenesis and experimental approaches and tools, by experts and opinion leaders in their respective fields.
By thoroughly and concisely covering whole aspects of HCC care, Hepatocellular Carcinoma serves as a valuable reference for multidisciplinary readers, and promotes the development of personalized precision care strategies that lead to substantial improvement of disease burden and patient prognosis in HCC.
Editors and Affiliations
-
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA
Yujin Hoshida
About the editor
Yujin Hoshida
University of Texas Southwestern Medical Center
Dallas, TX
USA
Bibliographic Information
Book Title: Hepatocellular Carcinoma
Book Subtitle: Translational Precision Medicine Approaches
Editors: Yujin Hoshida
Series Title: Molecular and Translational Medicine
DOI: https://doi.org/10.1007/978-3-030-21540-8
Publisher: Humana Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Nature Switzerland AG 2019
Hardcover ISBN: 978-3-030-21539-2Published: 20 August 2019
Softcover ISBN: 978-3-030-21542-2Published: 20 August 2020
eBook ISBN: 978-3-030-21540-8Published: 05 August 2019
Series ISSN: 2197-7852
Series E-ISSN: 2197-7860
Edition Number: 1
Number of Pages: XV, 364
Number of Illustrations: 19 b/w illustrations, 37 illustrations in colour
Topics: Pathology, Oncology, Gastroenterology, Hepatology